Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Benitec Biopharma Limited (BNTC) had Weighted-Average Shares Outstanding (Diluted) of 36.21M for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-37.92M |
|
-- |
|
-- |
|
$41.77M |
|
$-41.77M |
|
$3.85M |
|
$-37.92M |
|
$-37.92M |
|
$-37.92M |
|
$-37.92M |
|
$-37.92M |
|
$-37.92M |
|
$-41.77M |
|
$-41.70M |
|
36.21M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
36.21M |
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$98.52M |
|
$0.13M |
|
$1.07M |
|
$99.59M |
|
$1.80M |
|
$0.49M |
|
$0.49M |
|
$2.30M |
|
$97.30M |
|
$97.30M |
|
$97.30M |
|
26.25M |
|
| Cash Flow Statement Financials | |
$-23.59M |
|
$-0.02M |
|
$70.48M |
|
$50.93M |
|
$97.86M |
|
$46.93M |
|
$17.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
54.67 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.97% |
|
-38.97% |
|
-38.07% |
|
-38.77% |
|
$3.71 |
|
$-0.65 |
|
$-0.65 |
|